FI800846A - En hybridcell-linje foer framstaellning av en monoklonal antikropp mot maenskliga t-celler antikroppen samt terapeutiska och diagnostiska metoder i vilka antikroppen anvaendes - Google Patents

En hybridcell-linje foer framstaellning av en monoklonal antikropp mot maenskliga t-celler antikroppen samt terapeutiska och diagnostiska metoder i vilka antikroppen anvaendes

Info

Publication number
FI800846A
FI800846A FI800846A FI800846A FI800846A FI 800846 A FI800846 A FI 800846A FI 800846 A FI800846 A FI 800846A FI 800846 A FI800846 A FI 800846A FI 800846 A FI800846 A FI 800846A
Authority
FI
Finland
Prior art keywords
antikroppen
cell line
monoclonal
therapeutic
enhybrid
Prior art date
Application number
FI800846A
Other languages
English (en)
Other versions
FI75362C (fi
FI75362B (fi
Inventor
Patrick Chung-Shu Kung
Gideon Goldstein
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21807977&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI800846(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of FI800846A publication Critical patent/FI800846A/fi
Priority to FI844703A priority Critical patent/FI75229C/fi
Application granted granted Critical
Publication of FI75362B publication Critical patent/FI75362B/fi
Publication of FI75362C publication Critical patent/FI75362C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3061—Blood cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fuel Cell (AREA)
FI800846A 1979-03-20 1980-03-19 Foerfarande foer framstaellning av en monoklonal antikropp mot maenniskans t-celler, medelst en ny hybridcellinje. FI75362C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI844703A FI75229C (fi) 1979-03-20 1984-11-29 Diagnostiskt foerfarande, vid vilket man anvaender en ny monoklonal antikropp specifik mot maenniskans t-celler.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/022,132 US4363799A (en) 1979-03-20 1979-03-20 Monoclonal antibody to human T cells, and methods for preparing same
US2213279 1979-03-20

Publications (3)

Publication Number Publication Date
FI800846A true FI800846A (fi) 1980-09-21
FI75362B FI75362B (fi) 1988-02-29
FI75362C FI75362C (fi) 1988-06-09

Family

ID=21807977

Family Applications (1)

Application Number Title Priority Date Filing Date
FI800846A FI75362C (fi) 1979-03-20 1980-03-19 Foerfarande foer framstaellning av en monoklonal antikropp mot maenniskans t-celler, medelst en ny hybridcellinje.

Country Status (22)

Country Link
US (1) US4363799A (fi)
EP (1) EP0017381B1 (fi)
JP (2) JPS55127321A (fi)
AT (1) ATE14233T1 (fi)
AU (1) AU544771B2 (fi)
CA (1) CA1149281A (fi)
DE (2) DE3070848D1 (fi)
DK (1) DK154086C (fi)
ES (1) ES489757A0 (fi)
FI (1) FI75362C (fi)
GR (1) GR68040B (fi)
HK (1) HK23686A (fi)
IE (1) IE50420B1 (fi)
IL (1) IL59622A (fi)
MY (1) MY8600535A (fi)
NO (1) NO159882C (fi)
NZ (1) NZ193173A (fi)
PH (1) PH17056A (fi)
PT (1) PT70978B (fi)
SG (1) SG6486G (fi)
YU (1) YU43913B (fi)
ZA (1) ZA801604B (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4510244A (en) * 1980-04-17 1985-04-09 The Board Of Trustees Of The Leland Stanford Jr. University Cell labeling with antigen-coupled microspheres
US4582797A (en) * 1980-09-25 1986-04-15 The Salk Institute For Biological Studies Monoclonal antibodies specific for human hematopoietic cell surface glycoproteins
US4608337A (en) * 1980-11-07 1986-08-26 The Wistar Institute Human hybridomas and the production of human monoclonal antibodies by human hybridomas
DE3105150A1 (de) * 1981-02-12 1982-08-19 Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg Herstellung von anti-t-lymphozyten-globulin.
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4659655A (en) * 1981-11-25 1987-04-21 Bio-Response, Inc. Method for isolating product-producing cells
US4657852A (en) * 1982-04-02 1987-04-14 The Board Of Trustees Of The Leland Stanford Junior University Method for B cell typing of total human lymphocyte sample
US4471056A (en) * 1982-04-02 1984-09-11 The Board Of Trustees Of The Leland Stanford Junior University Method for HLA-DR typing of total human lymphocyte sample
US4511662A (en) * 1982-06-18 1985-04-16 Bio-Rad Laboratories, Inc. Simultaneous assay for T and B lymphocyte populations and subpopulations
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4500637A (en) * 1982-07-19 1985-02-19 The United States Of America As Represented By The Department Of Health And Human Services Prevention of graft versus host disease following bone marrow transplantation
US4550086A (en) * 1983-02-16 1985-10-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies that recognize human T cells
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
US4643971A (en) * 1983-03-11 1987-02-17 Sloan-Kettering Institute Monoclonal antibodies to human bladder and ureter cancers and method
US4645738A (en) * 1983-09-30 1987-02-24 Memorial Sloan-Kettering Institute Cancer Center Method for differential diagnosis of T cell leukemias using monoclonal antibodies
JPS60231699A (ja) * 1983-11-09 1985-11-18 Aichiken 正常及び悪性ヒト造血器細胞に対するモノクローナル抗体
US4649106A (en) * 1984-06-01 1987-03-10 Dana-Farber Cancer Institute, Inc. Distinguishing subsets of human cells
US5431897A (en) * 1985-04-19 1995-07-11 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
US4970299A (en) * 1986-07-03 1990-11-13 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies selective for prostate cancer
US4882424A (en) * 1987-05-11 1989-11-21 Dana-Farber Cancer Institute, Inc. Activation antigen
US5298419A (en) * 1988-03-31 1994-03-29 The Arizona Board Of Regents On Behalf Of The University Of Arizona Human hybridomas and monoclonal antibodies which bind both gp41 and gp120 envelope proteins of human immunodeficiency virus
US4996298A (en) * 1988-04-20 1991-02-26 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US4921789A (en) * 1988-04-20 1990-05-01 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US4892933A (en) * 1988-04-20 1990-01-09 New England Deaconess Hospital Corporation Monoclonal antibody for colorectal carcinoma
US5601819A (en) * 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
IT1249051B (it) * 1991-02-26 1995-02-11 Italfarmaco Spa Immunotossina da anticorpi monoclonali anti-cd5
WO1999026658A1 (en) 1997-11-24 1999-06-03 Wong Johnson T Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
EP1802648A2 (en) 2004-09-10 2007-07-04 Cornell Research Foundation, Inc. Betulinol derivatives as anti-cancer agents
BR112013006146B8 (pt) 2010-09-15 2022-10-11 Dow Agrosciences Llc Anticorpos monoclonais, linhagens de célula de hibridoma e métodos para identificar a presença e para a determinação quantitativa de uma enzima aad-1 que confere resistência ao ácido 2,4-diclorofenoxiacético
SG11202110287QA (en) 2019-04-24 2021-10-28 Heidelberg Pharma Res Gmbh Amatoxin antibody-drug conjugates and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4284412A (en) * 1979-07-13 1981-08-18 Ortho Diagnostics, Inc. Method and apparatus for automated identification and enumeration of specified blood cell subclasses

Also Published As

Publication number Publication date
NO159882C (no) 1989-02-15
JPS6362518B2 (fi) 1988-12-02
ZA801604B (en) 1981-10-28
JPH0223156B2 (fi) 1990-05-23
NO159882B (no) 1988-11-07
ES8103975A1 (es) 1981-04-16
ES489757A0 (es) 1981-04-16
IL59622A (en) 1983-12-30
MY8600535A (en) 1986-12-31
AU544771B2 (en) 1985-06-13
NZ193173A (en) 1984-07-06
NO800793L (no) 1980-09-22
JPS55127321A (en) 1980-10-02
YU74280A (en) 1984-08-31
PT70978A (en) 1980-04-01
SG6486G (en) 1986-08-01
YU43913B (en) 1989-12-31
DE3070848D1 (en) 1985-08-14
FI75362C (fi) 1988-06-09
CA1149281A (en) 1983-07-05
EP0017381A2 (en) 1980-10-15
JPS63294779A (ja) 1988-12-01
IE800565L (en) 1980-09-20
US4363799A (en) 1982-12-14
DE17381T1 (de) 1984-10-11
HK23686A (en) 1986-04-11
DK154086B (da) 1988-10-10
DK117280A (da) 1980-09-21
IE50420B1 (en) 1986-04-16
ATE14233T1 (de) 1985-07-15
IL59622A0 (en) 1980-06-30
PT70978B (en) 1981-06-25
EP0017381B1 (en) 1985-07-10
EP0017381A3 (en) 1981-01-07
GR68040B (fi) 1981-10-27
AU5659880A (en) 1980-09-25
FI75362B (fi) 1988-02-29
PH17056A (en) 1984-05-17
DK154086C (da) 1989-02-27

Similar Documents

Publication Publication Date Title
FI800846A (fi) En hybridcell-linje foer framstaellning av en monoklonal antikropp mot maenskliga t-celler antikroppen samt terapeutiska och diagnostiska metoder i vilka antikroppen anvaendes
FI801343A (fi) En hybridcell-linje foer framstaellning av en monoklonal antikropp mot maenskliga hjaelpare-t-celler antikroppen samt terapeutiska och diagnostiska metoder i vilka antikroppen anvaendes
ES497425A0 (es) Un metodo de preparacion de un anticuerpo monoclonal.
FI801342A (fi) En hybridcell-linje foer framstaellning av en komplementbindande monoklonal antikropp mot maenskliga t-celler antikroppen samt terapeutiska och diagnostiska metoder i vilka antikroppen anvaendes
FI810026L (fi) Hybridcellinje foer framstaellning av monoklonal antikropp mot maenskliga t-cellers antigener den saolunda framstaellda antikroppen samt terapeutiska och diagnostiska metoder i vilka antikroppen anvaends
ES497422A0 (es) Un metodo de preparacion de un inticuerpo monocloral.
ES498359A0 (es) Un metodo de preparacion de un anticuerpo monoclonal.
ES497424A0 (es) Un metodo de preparacion de un anticuerpo monoclonal.
FI803755L (fi) En hybridcell-linje foer framstaellning av en monoklonal antikropp mot en maensklig tymosytantigen antikroppen samt terapeutiska och diagnostiska metoder i vilka antikroppen anvaendes

Legal Events

Date Code Title Description
MA Patent expired

Owner name: ORTHO PHARMACEUTICAL CORPORATION